Small differences in genetic code from one person to the next could influence who develops side effects to chemotherapy. Andreas Butler, MD, oncologist at Mayo Clinic and senior author of the study, reported that three genes (EPHA5, ARHGEF10, and PRX) were the focus of their study and are the first to mine large swaths of the human genome for predictors. READ MORE
Source:Â HealthNewsDigest